Search Results - Chris Fourment

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

    Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study by Brian Bressler, Andrés Yarur, Mark S. Silverberg, Marielle Bassel, Emanuelle Bellaguarda, Chris Fourment, Anthie Gatopoulou, Pantelis Karatzas, Uri Kopylov, Giorgos D. Michalopoulos, Spyridon Michopoulos, Udayakumar Navaneethan, David T. Rubin, Jesse Siffledeen, Andrew Singh, Konstantinos Soufleris, Dara Stein, Dirk Demuth, Gerassimos J. Mantzaris

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: